WinstonWınston
Lifeward logo

Lifeward

LFWD
14
Medical - Devices · Healthcare
Price
$7.91
+0.07 (+0.89%)
Market Cap
$12.7M
Exchange
NASDAQ Capital Market
Winston Score
14
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+1934.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 570K (2021) → 11.6M (2025)

Lifeward Ltd. is a medical device company that makes robotic systems to help people with mobility disabilities walk again. Its main product is the ReWalk exoskeleton, a wearable robotic suit that straps onto a person's legs and helps them stand up and walk. The company sells primarily to rehabilitation hospitals, veterans' programs, and individual patients, mostly in the United States and Europe.

Lifeward earns money by selling its exoskeleton devices and through service and support contracts. The company is small, with a market cap near zero, and it operates at a significant loss — spending far more than it brings in each year. ReWalk was one of the first FDA-cleared powered exoskeletons for home use, which gives it a regulatory head start, but the company faces intense pressure to expand insurance coverage for its devices, since limited reimbursement from insurers remains the biggest barrier to wider adoption and a path to profitability.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-22.1% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-21.4% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$3M/ year

Declining (-30% vs prior year)

14.7% of revenue

In line with sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

3.3%ownership

Relatively low insider ownership

Cash Runway

~9 months

$11M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Short runway — potential dilution ahead through share issuance

Cash watch

Lifeward has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
34.2%
Modest — 34.2% gross margin
Operating Margin
-263.5%
Losing money on operations — -263.5%
ROCE
-76.2%
Weak — -76.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-17.7%
Shrinking sales (-17.7% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-71.8%
Burning cash (-71.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
1.16
Elevated debt (1.16)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial